迈克生物:目前已有9家医院实际运行智慧化实验室系统,12家正在实施中,另有多家处于前期方案设计阶段

Core Viewpoint - The company acknowledges performance pressure due to market competition and prior investments but believes that promoting "smart laboratories" is a necessary market strategy to navigate industry cycles and seize structural opportunities [2]. Group 1: Company Strategy - The company has implemented smart laboratory systems in 9 hospitals, with 12 more in the implementation phase and several others in the preliminary design stage [2]. - The company encourages stakeholders to monitor detailed updates in its regular reports [2]. Group 2: Market Conditions - The company is facing challenges from market saturation and the impact of previous investments on performance [2]. - The strategy of promoting smart laboratories is seen as a way to overcome these challenges and capitalize on emerging opportunities within the industry [2].